Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Future Medicine Co., Ltd, 54 Changup-ro, Sujeong-gu, Seongnam, Gyeonggi-do 13449, Republic of Korea.
Bioorg Med Chem. 2024 Dec 1;115:117986. doi: 10.1016/j.bmc.2024.117986. Epub 2024 Nov 2.
This study investigated the impact of conformation on the binding affinity of carbanucleosides to A and A adenosine receptors (ARs). A series of nucleosides, including saturated, unsaturated, North (N)-methano, and South (S)-methanocarbanucleosides was prepared, and their binding affinities to AAR and AAR were assessed. Biological evaluations revealed that all synthesized (S)-methanocarbanucleosides had negligible binding to both receptors, and most (N)-methanocarbanucleosides exhibited high binding affinities. Molecular docking analysis showed that the (N)-methanocarbanucleoside 6a exhibited favorable interactions and minimal steric clashes in both AAR and AAR. Conversely, the (S)-methanocarbanucleoside 7a appears to encounter significant steric clashes, which impeded its binding to AAR. Furthermore, when adopting the South conformation 7a was unable to bind to AAR. Expanding upon the (N)-methanocarba moiety, various C8-aromatic groups were introduced to convert AAR agonists into antagonists and these modified compounds also exhibited strong binding affinity. These results suggest that the North conformation is favored by both AAR and AAR, and that (N)-methanocarbanucleosides can serve as versatile structural moieties for dual targeting of AAR and AAR. These findings offer promising avenues for the development of dual ligands for therapeutic applications in obesity and immunotherapy.
本研究考察了构象对碳氮核苷与 A 和 A 腺苷受体(AR)结合亲和力的影响。合成了一系列核苷,包括饱和、不饱和、North(N)-甲撑和 South(S)-甲撑碳核苷,并评估了它们与 AAR 和 AAR 的结合亲和力。生物评价结果表明,所有合成的(S)-甲撑碳核苷对两种受体均具有可忽略的结合能力,而大多数(N)-甲撑碳核苷则表现出高的结合亲和力。分子对接分析表明,(N)-甲撑碳核苷 6a 在 AAR 和 AAR 中均表现出有利的相互作用和最小的空间位阻。相比之下,(S)-甲撑碳核苷 7a 似乎遇到了显著的空间位阻,阻碍了其与 AAR 的结合。此外,当采用 South 构象时,7a 无法与 AAR 结合。在(N)-甲撑碳部分的基础上,引入了各种 C8-芳基基团,将 AAR 激动剂转化为拮抗剂,这些修饰化合物也表现出很强的结合亲和力。这些结果表明,North 构象既被 AAR 又被 AAR 所偏爱,并且(N)-甲撑碳核苷可以作为双重靶向 AAR 和 AAR 的多功能结构部分。这些发现为肥胖症和免疫治疗中双重配体的开发提供了有希望的途径。